Daler Inn Limited, has been allocated 1,826,252 shares in the Rights Issue and will following the Transaction increase its holding to 10,909,816 shares, but its holding of outstanding shares and votes in the Company will be decreased from 7.9% to 3.74%.
Exproco Limited, a Company controlled by Jonny Hansen, COO in the Company, has been allocated 143,187 shares in the Rights Issue and will following completion of the Transaction increase its holding to 7,503,187 shares. Exproco Limited's holding of outstanding shares and votes in the Company will simultaneously be decreased from 6.4% to 2.57%. The consolidated holding of Exproco Limited and Jonny Hansen following the Transaction is 7,700,315 shares, equal to 2,64% of the outstanding shares and votes in the Company.
Certain primary insiders and close associates have been allocated new shares, including but not limited to:
Henrik Badin, CEO of the Company, has been allocated 107,368 new shares.
Badin Invest Limited, a company closely associated to Henrik Badin, CEO of the Company, has been allocated 203,000 new shares.
Thomas Borgen, Chairman of the Board of Directors of the Company, has been allocated 104,392 new shares.
TFBConsulting AS, a company closely associated to Thomas Borgen, Chairman of the Board of Directors of the Company, has been allocated 248,899 new shares.
Jonny Hansen, COO of the Company, has been allocated 117,128 new shares, as further specified above
Exproco Limited, a company closely associated to Jonny Hansen, COO of the Company, has been allocated 143,187 new shares.
Egil Haugsdal, Member of the Board of Directors of the Company, has been allocated 55,636 new shares.
Jens Langebrekke, Group Finance Manager, has been allocated 3,660 new shares.
Mari Danielsen Stamsø, Financial Advisor to the Company, has been allocated 4,225 new shares.
Limamo Invest AS, a company closely associated to Mari Stamsø, Financial Advisor to the Company, has been allocated 4,880 new shares.
Please see the attached forms for further details about the transactions.
This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
Attachment

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.